This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Omland, T. Articles by Caidahl, K. Search for Related Content PubMed Articles by Omland, T. Articles by Caidahl, K.

Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes

Torbjørn Omland, MD, PhD, MPH^_*,, Thor Ueland, PhD^,1, Anna M. Jansson, MD, Anita Persson, MSc^||, Thomas Karlsson, MSc^¶, Camilla Smith, MD, Johan Herlitz, MD, PhD^¶, Pål Aukrust, MD, PhD^,1, Marianne Hartford, MD, PhD^¶,# and Kenneth Caidahl, MD, PhD^,||,_*

^_* Department of Medicine, Akershus University Hospital, Lørenskog, Norway
Faculty of Medicine, University of Oslo, Oslo, Norway
Research Institute for Internal Medicine, Rikshospitalet, Oslo, Norway
Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
^|| Department of Clinical Physiology, Sahlgrenska University Hospital, Göteborg, Sweden
^¶ Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden
^# AstraZeneca R&D, Mölndal, Sweden.

View larger version (17K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Osteoprotegerin and Long-Term Mortality Association between osteoprotegerin levels by quartiles and long-term mortality.

View larger version (11K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Osteoprotegerin and Heart Failure Hospitalization Association between osteoprotegerin levels by quartiles and the incidence of heart failure hospitalizations.